Be the first to like this.
3 comment(s). Last comment by winwinwin 2012-11-22 15:21
Posted by moven00 > 2012-11-21 14:17 | Report Abuse
LKT and Genting is feeling the pressure to deliver and expand its profit.
Well, pharmaceutical might sounds interesting to many. But reality bits. It is a long and tough journey. Simply look at gain such as Pzifer and Roche. They are also research pharmaceutical company, amid Giant of pharmaceutical. But also struggling and make lotsa research that cost billions yet still not that successful. This Giant even have to close down some of their factories in US.
Posted by winwinwin > 2012-11-22 15:21 | Report Abuse
Genting shares will get dumped....this is similar to Gamuda buying some phone company many years ago.....once you stray....you won't be loved !
No result.
1
2
Good Articles to Share
Trump win to test limit of presidential power; Harris concedes but vows 'fight'
4
TA Sector Research
5
BFM Podcast
6
BFM Podcast
7
BFM Podcast
8
BFM Podcast
#
Stock
Score
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
KC Loh
13,701 posts
Posted by KC Loh > 2012-11-21 12:28 | Report Abuse
LKT seems to be out of ideas. This may be profitable in future, but as the analyst correctly mentioned, not their core operations! what signal is he giving to the investment frat? no more interested in pursuing Echo?